Overview

Webcast ImageWebcast - Replay
Martek Biosciences Corporation at Needham & Company Biotechnology and Medical Technology Conference
06/12/08 at 1:30 p.m. ET
Corporate Profile

Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life’sDHA™, a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula, and supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.

 
Recent NewsMore >>
DateTitle 
06/26/08Results of Study in Pre-School Children Published in Clinical Pediatrics Adds to Support for Importance of Dietary DHA IntakePrinter Friendly Version
06/25/08Eastern European Supplement Leader Walmark Launches Prenatal Product Featuring Martek's life'sDHATMPrinter Friendly Version
06/04/08Martek Announces Second Quarter 2008 Financial ResultsPrinter Friendly Version
06/04/08Martek's life'sDHA TM Now Available in Rachel'sTM Yogurt at Grocery Retailers NationwidePrinter Friendly Version
Stock Quote
MATK (common stock)
ExchangeNASDAQ GS (US Dollar)
Price$34.67
Change (%) Stock is Up 1.51 (4.55%)
Volume515,600
Data as of 07/08/08 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Upcoming EventsMore >>
There are currently no events scheduled.
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Martek Biosciences Corporation posts new information to the site. Just enter your e-mail address and click Submit.
 
Copyright © 2007 MarketWatch, Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data is provided by Interactive Real Time Services Data and subject to the Term of Use .
Changes in price and volume are subject to market activity.